The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.
Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders
Open accessAbstract
This paper proposes a heuristic framework for an Addictions Neuroclinical Assessment (ANA) that incorporates key functional domains derived from the neurocircuitry of addiction. We review how addictive disorders (AD) are presently diagnosed, and the need for new neuroclinical measures to differentiate patients who meet clinical criteria for addiction to the same agent while differing in etiology, prognosis and treatment response. The need for a better understanding of the mechanisms provoking and maintaining addiction, as evidenced by the limitations of current treatments and within-diagnosis clinical heterogeneity, is articulated. In addition, recent changes in the nosology of AD, challenges to current classification systems, and prior attempts to subtype individuals with AD are described. Complementary initiatives, including the Research Domain Criteria (RDoC) project, which have established frameworks for the neuroscience of psychiatric disorders, are discussed. Three domains, executive function, incentive salience, and negative emotionality, tied to different phases in the cycle of addiction, form the core functional elements of AD. Measurement of these domains in epidemiologic, genetic, clinical, and treatment studies will provide the underpinnings for an understanding of cross-population and temporal variation in addictions, shared mechanisms in addictive disorders, impact of changing environmental influences, and gene identification. Finally, we show that it is practical to implement such a deep neuroclinical assessment using a combination of neuroimaging and performance measures. Neuroclinical assessment is key to reconceptualizing the nosology of AD on the basis of process and etiology, an advance that can lead to improved prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Advances in diagnosis that reflect such an endophenotype or research domain criterion approach will synergistically combine with advances in neurobiology to promote novel pharmacotherapeutic, brain stimulation (ie, transcranial magnetic stimulation and direct electrical stimulation), and behavioural treatments.186”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [186]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the Addictions Neuroclinical Assessment, five subdomains of negative emotional states that can be operationally measured in human laboratory settings and paralleled by animal models were outlined (Kwako et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Kwako et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From a nosology perspective, the Addictions Neuroclinical Assessment framework allows the identification of individuals with phenotypes that signal dysregulation in this domain (Kwako et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Kwako et al., 2016
Experimental — accuracy not yet measuredIn the citing paper
“a neurofunctional domain that is postulated to be relevant to early onset of risky alcohol use and the development and maintenance of AUDs (15).”
From Impact of Childhood Trauma on Executive Function in Adolescence—Mediating Functional Brain Networks and Prediction of High-Risk Drinking (2020) · cites this paper as [15]
In the citing paper
“third, it integrates measures for an understanding of the overall functioning of a domain”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“The ANA domains, which encompass only a small fraction of the biomarker space for addiction, are incentive salience (see Glossary), negative emotionality, and executive function [2].”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“The ANA domains, which encompass only a small fraction of the biomarker space for addiction, are incentive salience (see Glossary), negative emotionality, and executive function [2].”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“fourth, it is a research approach for assessment of addiction, not capable, or intended to diagnose DSM-based alcohol/substance use disorders.”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“first, it targets measures towards domains that are mechanistically important”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067
Development and validation of a brief screening version of the Childhood Trauma Questionnaire
Bernstein, D. P., Stein, J. A., Newcomb, M. D., Walker, E., Pogge, D., Ahluvalia, T., Stokes, J., Handelsman, L., Medrano, M., Desmond, D., et al. (2003) · Child Abuse & Neglect · doi:10.1016/s0145-2134(02)00541-0 · Cited by 6,419
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Self-citationBagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90005-1 · Cited by 5,293
The Fifth Edition of the Addiction Severity Index.
Mclellan, A., Kushner, H., Metzger, D., Peters, R., Smith, I. E., Grissom, G. R., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,280
Cited by
Sorted by citations
Neurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698
Self-citationKotov, R., Krueger, R. F., Watson, D., Cicero, D. C., Conway, C. C., DeYoung, C. G., Eaton, N. R., Forbes, M. K., Hallquist, M. N., Latzman, R. D., et al. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081219-093304 · Cited by 596
Advances in the science and treatment of alcohol use disorder
Witkiewitz, K. A., Litten, R. Z., & Leggio, L. (2019) · Science Advances · doi:10.1126/sciadv.aax4043 · Cited by 629
Self-citationDrug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Self-citationAlcohol use disorder and sleep disturbances: a feed-forward allostatic framework
Koob, G. F., & Colrain, I. M. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0446-0 · Cited by 302
Self-citationYücel, M., Oldenhof, E., Ahmed, S. H., Belin, D., Billieux, J., Bowden‐Jones, H., Carter, A., Chamberlain, S. R., Clark, L., Connor, J. P., et al. (2018) · Addiction · doi:10.1111/add.14424 · Cited by 247
Hazardous drinking and alcohol use disorders
MacKillop, J. M., Agabio, R., Ewing, S. W. F., Heilig, M. A., Kelly, J. F., Leggio, L., Lingford-Hughes, A. R., Palmer, A. A., Parry, C. D. H., Ray, L. A., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00406-1 · Cited by 251
Carroll, K. M., & Kiluk, B. D. (2017) · Psychology of Addictive Behaviors · doi:10.1037/adb0000311 · Cited by 227
Cognitive impairment in substance use disorders
Ramey, T., & Regier, P. S. (2018) · CNS Spectrums · doi:10.1017/s1092852918001426 · Cited by 219
Borderline personality disorder and substance use disorders: an updated review
Trull, T. J., Freeman, L. K., Vebares, T. J., Choate, A. M., Helle, A. C., & Wycoff, A. M. (2018) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-018-0093-9 · Cited by 196
Verdejo‐García, A., García–Fernández, G., & Dom, G. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.3/gdom · Cited by 201
Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11
Saunders, J. B. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000332 · Cited by 190
Anker, J. J. (2019) · Alcohol research · doi:10.35946/arcr.v40.1.03 · Cited by 172
Addiction as a coping response: hyperkatifeia, deaths of despair, and COVID-19
Koob, G. F., Powell, P., & White, A. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20091375 · Cited by 166
Self-citationGenetic studies of alcohol dependence in the context of the addiction cycle
Reilly, M. T., Noronha, A., Goldman, D. A., & Koob, G. F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.017 · Cited by 163
Self-citationNeurofunctional domains derived from deep behavioral phenotyping in alcohol use disorder
Kwako, L. E., Schwandt, M. L., Ramchandani, V. A., Diazgranados, N., Koob, G. F., Volkow, N. D., Blanco, C., & Goldman, D. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18030357 · Cited by 138
Self-citationNIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted
Rasmussen, K., White, D. A., & Acri, J. B. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0292-5 · Cited by 128
Pathological overeating: emerging evidence for a compulsivity construct
Moore, C. F., Sabino, V., Koob, G. F., & Cottone, P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.269 · Cited by 126
Self-citationRay, L. A., Bujarski, S., Shoptaw, S., Roche, D. J., Heinzerling, K., & Miotto, K. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.10 · Cited by 118
Vassileva, J., & Conrod, P. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0137 · Cited by 118
Brain-wide functional architecture remodeling by alcohol dependence and abstinence
Kimbrough, A., Lurie, D. J., Collazo, A., Kreifeldt, M., Sidhu, H., Macedo, G. C., D’Esposito, M., Contet, C., & George, O. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909915117 · Cited by 97
Addiction Biomarkers: Dimensional Approaches to Understanding Addiction
Kwako, L. E., Bickel, W. K., & Goldman, D. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.12.007 · Cited by 103
Self-citationAlcohol Use Disorder Treatment: Problems and Solutions
Koob, G. F. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031323-115847 · Cited by 126
Self-citationPsychopathy: Current Knowledge and Future Directions
Patrick, C. J. (2022) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072720-012851 · Cited by 108
Emerging Role of Epigenetic Mechanisms in Alcohol Addiction
Berkel, T. D. M., & Pandey, S. C. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13338 · Cited by 102
Measurement of substance-free reinforcement in addiction: A systematic review
Acuff, S. F., Dennhardt, A. A., Correia, C. J., & Murphy, J. G. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.04.003 · Cited by 106
Neuroclinical Framework for the Role of Stress in Addiction
Kwako, L. E., & Koob, G. F. (2017) · Chronic Stress · doi:10.1177/2470547017698140 · Cited by 105
Self-citationVerdejo‐García, A., Lorenzetti, V., Manning, V., Piercy, H., Bruno, R., Hester, R., Pennington, D., Tolomeo, S., Arunogiri, S., Bates, M. E., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00877 · Cited by 95
Boness, C. L., Watts, A. L., Moeller, K. N., & Sher, K. J. (2021) · Psychological Bulletin · doi:10.1037/bul0000333 · Cited by 102
Evidence for incentive salience sensitization as a pathway to alcohol use disorder
Cofresí, R. U., Bartholow, B. D., & Piasecki, T. M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.009 · Cited by 94
Patrick, C. J., Iacono, W. G., & Venables, N. C. (2019) · Psychological Assessment · doi:10.1037/pas0000713 · Cited by 85
A dual process perspective on advances in cognitive science and alcohol use disorder
Lindgren, K. P., Hendershot, C. S., Ramirez, J. J., Bernat, E. M., Rangel‐Gomez, M., Peterson, K. P., & Murphy, J. G. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.04.002 · Cited by 80
Silveira, S., Shah, R., Nooner, K. B., Nagel, B. J., Tapert, S. F., de Bellis, M. D., & Mishra, J. (2020) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.01.011 · Cited by 68
Alcohol Use Disorder and Antisocial and Borderline Personality Disorders
Helle, A. C. (2019) · Alcohol research · doi:10.35946/arcr.v40.1.05 · Cited by 84
Verdejo‐García, A., Rezapour, T., Giddens, E., Zonoozi, A. K., Rafei, P., Berry, J., Caracuel, A., Copersino, M. L., Field, M., Garland, E. L., et al. (2022) · Addiction · doi:10.1111/add.16109 · Cited by 74
Litten, R. Z., Falk, D. E., Ryan, M. L., & Fertig, J. B. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13093 · Cited by 73
Self-citationThe Profound Heterogeneity of Substance Use Disorders: Implications for Treatment Development
Carroll, K. M. (2021) · Current Directions in Psychological Science · doi:10.1177/09637214211026984 · Cited by 67
Addictions NeuroImaging Assessment (ANIA): Towards an integrative framework for alcohol use disorder
Voon, V., Grodin, E. N., Mandali, A., Morris, L. S., Doñamayor, N., Weidacker, K., Kwako, L. E., Goldman, D. A., Koob, G. F., & Momenan, R. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.004 · Cited by 72
Self-citationKoob, G. F. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4484-6 · Cited by 73
Self-citationBlunted Reward Sensitivity and Trait Disinhibition Interact to Predict Substance Use Problems
Joyner, K. J., Bowyer, C. B., Yancey, J. R., Venables, N. C., Foell, J., Worthy, D. A., Hajcak, G., Bartholow, B. D., & Patrick, C. J. (2019) · Clinical Psychological Science · doi:10.1177/2167702619838480 · Cited by 73
Maisto, S. A., Hallgren, K. A., Roos, C. R., & Witkiewitz, K. A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.03.011 · Cited by 71
Nock, N. L., Minnes, S., & Alberts, J. L. (2017) · Birth Defects Research · doi:10.1002/bdr2.1182 · Cited by 61
Addictions Neuroclinical Assessment: A reverse translational approach
Kwako, L. E., Momenan, R., Grodin, E. N., Litten, R. Z., Koob, G. F., & Goldman, D. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.006 · Cited by 67
Self-citationWilcox, C. E., Abbott, C., & Calhoun, V. D. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.011 · Cited by 67
Watts, A. L., Boness, C. L., Loeffelman, J. E., Steinley, D., & Sher, K. J. (2021) · Journal of Abnormal Psychology · doi:10.1037/abn0000678 · Cited by 58
Lee, M. R., Sankar, V., Hammer, A., Kennedy, W. G., Barb, J. J., McQueen, P. G., & Leggio, L. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.05.008 · Cited by 62
Establishing norms for error-related brain activity during the arrow Flanker task among young adults
Imburgio, M. J., Banica, I., Hill, K. E., Weinberg, A., Foti, D., & MacNamara, A. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116694 · Cited by 61
Le, T. M., Potvin, S., Zhornitsky, S., & Li, C. R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.028 · Cited by 59
Neuroscience of Compulsive Eating Behavior
Moore, C. F., Sabino, V., Koob, G. F., & Cottone, P. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00469 · Cited by 56
Self-citationVotaw, V. R., Pearson, M. R., Stein, E., & Witkiewitz, K. A. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14283 · Cited by 54
The Genetically Informed Neurobiology of Addiction (GINA) model
Bogdan, R., Hatoum, A. S., Johnson, E. C., & Arpana Agrawal, A. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00656-8 · Cited by 56
The future of translational research on alcohol use disorder
Ray, L. A., Grodin, E. N., Leggio, L., Bechtholt, A. J., Becker, H. C., Ewing, S. W. F., Jentsch, D., King, A. C., Mason, B. J., O’Malley, S. S., et al. (2020) · Addiction Biology · doi:10.1111/adb.12903 · Cited by 51
Self-citationEmerging pharmacotherapies for alcohol use disorder
Mason, B. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.032 · Cited by 47
Clinical Psychological Science
Wright, A. G. C., & Hallquist, M. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316995808.001 · Cited by 47
Closing the brain–heart loop: Towards more holistic models of addiction and addiction recovery
Eddie, D., Bates, M. E., & Buckman, J. F. (2020) · Addiction Biology · doi:10.1111/adb.12958 · Cited by 48
Perkins, E. R., Joyner, K. J., Patrick, C. J., Bartholow, B. D., Latzman, R. D., DeYoung, C. G., Kotov, R., Reininghaus, U., Cooper, S. E., Afzali, M. H., et al. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.1/eperkins · Cited by 49
Hien, D. A., López‐Castro, T., Fitzpatrick, S., Ruglass, L. M., Fertuck, E. A., & Melara, R. D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.022 · Cited by 46
Rawls, E., Kummerfeld, E., & Zilverstand, A. (2021) · Communications Biology · doi:10.1038/s42003-021-01955-z · Cited by 45
Interfacing neural constructs with the Hierarchical Taxonomy of Psychopathology : ‘Why' and ‘how'
Perkins, E. R., Latzman, R. D., & Patrick, C. J. (2019) · Personality and Mental Health · doi:10.1002/pmh.1460 · Cited by 43
Development and feasibility study of an addiction focused phenotyping assessment battery
Keyser-Marcus, L., Ramey, T., Bjork, J., Adams, A. S., & Moeller, F. (2021) · American Journal on Addictions · doi:10.1111/ajad.13170 · Cited by 23
Toward a neurobehavioral trait conceptualization of depression proneness
Bowyer, C. B., Joyner, K. J., Yancey, J. R., Venables, N. C., Hajcak, G., & Patrick, C. J. (2019) · Psychophysiology · doi:10.1111/psyp.13367 · Cited by 39
Cortical and amygdalar neuronal ensembles in alcohol seeking, drinking and withdrawal
George, O., & Hope, B. T. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.031 · Cited by 39
(Mis)understanding alcohol use disorder: Making the case for a public health first approach
Morris, J. K., Boness, C. L., & Burton, R. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111019 · Cited by 37
Nieto, S. J., Grodin, E. N., Green, R., & Ray, L. A. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108603 · Cited by 36
Brislin, S. J., & Patrick, C. J. (2019) · Clinical Psychological Science · doi:10.1177/2167702619856342 · Cited by 37
Subtypes in addiction and their neurobehavioral profiles across three functional domains
Drossel, G., Brucar, L. R., Rawls, E., Hendrickson, T. J., & Zilverstand, A. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02426-1 · Cited by 35
Webber, H. E., de Dios, C., Kessler, D. A., Schmitz, J. M., Lane, S. D., & Suchting, R. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104835 · Cited by 35
Pagni, B. A., Petridis, P. D., Podrebarac, S. K., Grinband, J., Claus, E. D., & Bogenschutz, M. P. (2024) · Scientific Reports · doi:10.1038/s41598-024-52967-8 · Cited by 37
Cannabis involvement and neuropsychological performance: findings from the Human Connectome Project
Petker, T. D., Owens, M. M., Amlung, M. T., Oshri, A., Sweet, L. H., & MacKillop, J. M. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180115 · Cited by 37
Exploring dopaminergic transmission in gambling addiction: A systematic translational review
Pettorruso, M., Zoratto, F., Miuli, A., Risio, L. D., Santorelli, M., Pierotti, A., Martinotti, G., Adriani, W., & Giannantonio, M. D. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.034 · Cited by 40
Bickel, W. K., Crabbe, J. C., & Sher, K. J. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13912 · Cited by 37
Precision Psychiatry and Dual Disorders
Szerman, N., & Peris, L. (2018) · Journal of Dual Diagnosis · doi:10.1080/15504263.2018.1512727 · Cited by 34
Zhou, Z., Blandino, P., Yuan, Q., Shen, P., Hodgkinson, C. A., Virkkunen, M. E., Watson, S. J., Akil, H., & Goldman, D. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820410116 · Cited by 30
Self-citationNeuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment?
Barba, R. J., Sión, A., Martínez-Maldonado, A., Centeno, I. D., Prieto-Montalvo, J., Navarrete, F., García‐Gutiérrez, M. S., Manzanares, J., & Rubio, G. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00676 · Cited by 35
Stein, E., Votaw, V. R., Swan, J. E., & Witkiewitz, K. A. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108227 · Cited by 30
Histone modifications, DNA methylation, and the epigenetic code of alcohol use disorder
Bohnsack, J. P., & Pandey, S. C. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.08.005 · Cited by 32
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Lohoff, F. W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.767506 · Cited by 37
Soltis, K. E., McDevitt‐Murphy, M. E., & Murphy, J. G. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13395 · Cited by 30
Litten, R. Z., Falk, D. E., Ryan, M. L., Fertig, J. B., & Leggio, L. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14233 · Cited by 31
Self-citationPettorruso, M., Giannantonio, M. D., Risio, L. D., Martinotti, G., & Koob, G. F. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000575 · Cited by 30
Self-citationSubstance-induced psychosis and cognitive functioning: A systematic review
Gicas, K. M., Parmar, P. K., Fabiano, G. F., & Mashhadi, F. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114361 · Cited by 32
Evidence-Based Assessment of Substance Use Disorder
Boness, C. L., González, J. C., Sleep, C. E., Venner, K. L., & Witkiewitz, K. A. (2023) · Assessment · doi:10.1177/10731911231177252 · Cited by 30
Kirsch, D. E., Belnap, M. A., Kady, A., & Ray, L. A. (2025) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2419540 · Cited by 29
Votaw, V. R., Stein, E., & Witkiewitz, K. A. (2021) · Alcohol and Alcoholism · doi:10.1093/alcalc/agab012 · Cited by 30
Ghali, S., Afifi, S., Suryadevara, V., Habab, Y., Hutcheson, A., Panjiyar, B., Davydov, G., Nashat, H., & Nath, T. S. (2023) · Cureus · doi:10.7759/cureus.43835 · Cited by 33
Facebook addiction and impulsive decision-making
Delaney, D., Stein, L. A. R., & Gruber, R. (2018) · Addiction Research & Theory · doi:10.1080/16066359.2017.1406482 · Cited by 29
An alcohol withdrawal test battery measuring multiple behavioral symptoms in mice
Metten, P., Schlumbohm, J. P., Huang, L. C., Greenberg, G. D., Hack, W. R., Spence, S. E., & Crabbe, J. C. (2017) · Alcohol · doi:10.1016/j.alcohol.2017.08.014 · Cited by 28
The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder
Shi, Z., Jagannathan, K., Padley, J. H., Wang, A., Fairchild, V. P., O’Brien, C. P., Childress, A. R., & Langleben, D. D. (2020) · Addiction Biology · doi:10.1111/adb.12977 · Cited by 28
Behavioral and Brain Activity Indices of Cognitive Control Deficits in Binge Drinkers
Molnar, S. M., Beaton, L. E., Happer, J. P., Holcomb, L. A., Huang, S., Arienzo, D., & Marinković, K. (2018) · Brain Sciences · doi:10.3390/brainsci8010009 · Cited by 30
Drinking beyond the binge threshold in a clinical sample of adolescents
Creswell, K. G., Chung, T. A., Skrzynski, C. J., Bachrach, R. L., Jackson, K. M., Clark, D. B., & Martin, C. S. (2020) · Addiction · doi:10.1111/add.14979 · Cited by 27
Lechner, W. V., Sidhu, N. K., Kittaneh, A. A., & Anand, A. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2019.01.017 · Cited by 38
Witkiewitz, K. A., Stein, E., Votaw, V. R., Hallgren, K. A., Gibson, B. C., Boness, C. L., Pearson, M. R., & Maisto, S. A. (2022) · Psychology of Addictive Behaviors · doi:10.1037/adb0000871 · Cited by 26
ADHD-Gaming Disorder Comorbidity in Children and Adolescents: A Narrative Review
Salerno, L., Becheri, L., & Pallanti, S. (2022) · Children · doi:10.3390/children9101528 · Cited by 34
Defining Substance Use Disorders: The Need for Peripheral Biomarkers
Bough, K. J., & Pollock, J. D. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.12.009 · Cited by 27
Animal models in addiction research: A dimensional approach
Lamontagne, S. J., & Olmstead, M. C. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.005 · Cited by 25
Kiluk, B. D. (2019) · Perspectives on Behavior Science · doi:10.1007/s40614-019-00205-2 · Cited by 25
New approaches to deep phenotyping in addictions.
Watts, A. L., Latzman, R. D., Boness, C. L., Kotov, R., Keyser‐Marcus, L., DeYoung, C. G., Krueger, R. F., Zald, D. H., Moeller, F. G., & Ramey, T. (2022) · Psychology of Addictive Behaviors · doi:10.1037/adb0000878 · Cited by 31
Examining Neural Reactivity to Gambling Cues in the Age of Online Betting
Brevers, D., Sescousse, G., Maurage, P., & Billieux, J. (2019) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-019-00177-2 · Cited by 32
Li, X., Kass, G., Wiers, C. E., & Shi, Z. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00593-9 · Cited by 28
Metadata
- Authors
- Kwako, L. E., Momenan, R., Litten, R. Z., Koob, G. F., & Goldman, D.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Kwako, Laura E.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 80
- Issue
- 3
- Pages
- 179-189
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC4870153
- OpenAlex
- W2207035985
- Semantic Scholar
- 621a35dbbd45d7e898e2999389a1fe6c88ac4688
- Cited by
- 395
- References
- 151
- Citations by year
- 2026: 48 · 2025: 32 · 2024: 46 · 2023: 38 · 2022: 43 · 2021: 47 · 2020: 38 · 2019: 46 · 2018: 24 · 2017: 27 · 2016: 6
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99‐AA999999)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- addiction, executive function, incentive salience, negative affectivity, addiction classification, Research Domain Criteria, neuroimaging, clinical heterogeneity, causes of addiction
- MeSH terms
- Emotions, Humans, Models, Psychological, Motivation, Neuropsychological Tests, Behavior, Addictive, Substance-Related Disorders, Executive Function, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
